Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Venture Atlas Labs is a venture capital firm dedicated to scaling health technology startups on a global scale. Founded with the mission to assist companies from Europe and Australia/New Zealand, the firm helps navigate the complexities of the U.S. commercialization landscape. By focusing on teaching, connecting scaleups with strategic partners, and exploring investment opportunities, Venture Atlas Labs positions itself as a key player in the health tech sector. Although specific details regarding fund size and assets under management (AUM) are not disclosed, the firm is recognized for its commitment to fostering innovation in healthcare technology. The leadership team comprises experts in health technology and venture capital, ensuring that startups receive the guidance they need to succeed in the competitive U.S. market. Venture Atlas Labs has built a reputation for its strategic approach to investment, emphasizing the importance of market entry strategies and partnerships.
Venture Atlas Labs targets international health technology startups that are looking to enter the U.S. market. The firm specializes in seed and Series A investments, focusing on the healthcare and digital health sectors. Their investment strategy includes providing comprehensive services such as commercialization strategy development, which helps startups understand the U.S. healthcare landscape and navigate regulatory challenges. Additionally, Venture Atlas Labs offers access to U.S. hospital pilots, allowing startups to test their products in real-world settings and gain valuable feedback. Tailored educational workshops for entrepreneurs are also a key component of their approach, equipping founders with the knowledge and skills necessary to succeed in the U.S. market. The firm operates the HealthTech Bridge accelerator, which provides startups with essential resources and guaranteed hospital pilots, further enhancing their chances of success. Through the Venture Atlas Labs Capital Network, they engage in deal syndication, reviewing and supporting early-stage deals that align with their investment thesis.
Venture Atlas Labs operates the HealthTech Bridge accelerator, which is designed to support health technology startups in their journey to enter the U.S. market. This program offers essential resources, including guaranteed access to hospital pilots, which allows startups to validate their solutions in real-world healthcare settings. The accelerator also provides tailored educational workshops that equip entrepreneurs with the knowledge needed to navigate the complexities of the U.S. commercialization landscape. Startups interested in participating in the HealthTech Bridge accelerator should reach out to Venture Atlas Labs for more information on application procedures and program details.
Venture Atlas Labs invests in startups at the seed and Series A stages, focusing on early-stage health technology companies.
The firm specializes in the healthcare and digital health sectors, targeting innovative health technology startups.
Founders interested in pitching to Venture Atlas Labs should prepare a comprehensive presentation that outlines their commercialization strategy, market potential, and how their technology addresses specific healthcare challenges.
Venture Atlas Labs primarily invests in startups from Europe and Australia/New Zealand that are looking to enter the U.S. market.
While specific application details are not provided, startups are encouraged to reach out to Venture Atlas Labs to discuss their business model and potential fit for investment.
Venture Atlas Labs offers support through its HealthTech Bridge accelerator, which includes access to hospital pilots and educational workshops tailored for entrepreneurs.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.